ITMCTR2200006028尚未招募未知
A randomized double-blind placebo-controlled study of Qingfei Jianpi desensitization prescription in early intervention of seasonal allergic rhinitis
Beijing Tongren Hospital ,Capital Medical University0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 65（—）
- 性别
- All
入选标准
- •(1) Patients who meet the diagnostic criteria of Western medicine and TCM syndrome differentiation criteria;
- •(2) At least 2 years in the same season, the onset season of each year is basically the same, and it is consistent with the pollination period of sensitized pollen;
- •(3) The age ranged from 18 to 65 years;
- •(4)Voluntarily participate in this experimental study and voluntarily terminate all treatments that may affect the evaluation of the tested drug;
- •(5)Sign informed consent
排除标准
- •(1)Those who have taken steroids in recent 2 weeks and antihistamines or topical steroids in 1 week;
- •(2)Perennial allergic rhinitis, acute rhinitis, or severe asthma combined with severe nasal septum deviation and hypertrophic rhinitis;
- •(3)Patients with serious primary diseases and psychosis such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system;
- •(4)Allergic to the drug;
- •(5)A woman who is pregnant, lactating or preparing for pregnancy.
研究者
相似试验
已完成
2 期
Efficacy of Ashwagandha extract on generalized anxiety disorderCTRI/2022/04/042133Arjuna Natural Private Limited60
进行中（未招募）
1 期
ALASCCA-A randomized double-blind placebo-controlled study with ASAtreatment in colorectal cancer patients with mutations in the PI3Ksignaling pathway.Colon or rectal cancer tumor stage II-III, tumor with somatic alterationsin PIK3CA, PIK3R1 or PTEN.MedDRA version: 21.0Level: LLTClassification code 10010029Term: Colorectal cancer NOSSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2015-004240-19-DKKarolinska University Hospital, Department of Molecular medicine and Surgery Karolinska Institutet, Gastrocentrum600
招募中
3 期
ALASCCA-A randomized double-blind placebo-controlled study with ASA treatment in colorectal cancer patients with mutations in the PI3K signaling pathway2024-513778-23-00Karolinska Institutet700
已完成
3 期
To determine whether Flexsure is safe, tolerable and effective in relieving symptoms of moderate osteoarthritis of the knee.CTRI/2011/07/001911Vital gNetics60
招募中
3 期
A randomized double-blind placebo-controlled study to evaluate the efficacy and safety of Cinryze® (C1 esterase inhibitor [human]) for the treatment of acute antibody-mediated rejection in kidney transplant patientskidney transplant10038430NL-OMON44758Shire7